Nanomedicines: Redefining traditional medicine

Area of Science:

• Nanomedicine
• Drug Delivery Systems
• Biotechnology

Background:

• Traditional drugs face limitations in targeting and permeability.
• Nanomedicines offer nanoscale drug delivery but face challenges in in vivo characterization, metabolism, and clinical translation.
• Safety concerns include immune response, cytotoxicity, and organ clearance, impacting efficacy.

Purpose of the Study:

• To review recent progress in various nanomedicines.
• To address shortcomings in current nanomedicine applications.
• To summarize methods for enhancing biosafety and in vivo efficacy.

Main Methods:

• Review of recent advancements in nanomedicine research.
• Analysis of nanomedicines including gold nanoparticles, nanorobots, and black phosphorus nanoparticles.
• Examination of applications in anti-tumor, antibacterial, ocular diseases, and arteriosclerosis.

Main Results:

• Summarized progress in diverse nanomedicine types and therapeutic areas.
• Identified key shortcomings related to in vivo behavior and clinical translation.
• Highlighted emerging strategies to overcome safety and efficacy barriers.

Conclusions:

• Nanomedicines show promise but require further research to address safety and efficacy.
• Improved understanding of in vivo properties and metabolism is crucial for clinical success.
• New approaches are being developed to enhance the therapeutic potential of nanomedicines.